Leaders In Computational Drug Discovery
The Research Team
Our team consists of scientists from Oak Ridge National Laboratory, Argonne National Laboratory, Berkley National Laboratory, Brookhaven National Laboratory, The University of Tennessee, University of Kentucky, The University of Alabama in Huntsville, and The City University of New York. We have also established collaborations with The University of Tennessee Health Science Center, Novartis, IBM Europe/Asia/EU, Google, NVIDIA, Scripps Research, University of L’Aquila, New York City College of Technology, and Harvard University. We have now grown to almost 30 members with an extensive network of collaborators pursuing a research program aimed at the discovery of small-molecule therapeutics for COVID-19. The methodology is structure-based drug discovery based on a three-step process.
Our team consists of scientists from Oak Ridge National Laboratory, Argonne National Laboratory, Berkley National Laboratory, Brookhaven National Laboratory, The University of Tennessee, University of Kentucky, The University of Alabama in Huntsville, and The City University of New York. We have also established collaborations with The University of Tennessee Health Science Center, Novartis, IBM Europe/Asia/EU, Google, NVIDIA, Scripps Research, University of L’Aquila, New York City College of Technology, and Harvard University. We have now grown to almost 30 members with an extensive network of collaborators pursuing a research program aimed at the discovery of small-molecule therapeutics for COVID-19. The methodology is structure-based drug discovery based on a three-step process.
Oak Ridge National Laboratory is managed by UT-Battelle LLC for the US Department of Energy
Learn about the Department of Energy’s Vulnerability Disclosure Program
|